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Invasive aspergillosis is a serious cause of mortality and morbidity in immunocompromised hosts. In particular, the emergence of 
multidrug-resistant fungi, such as Aspergillus calidoustus, poses a concern for both doctors and patients. Rapid screening in vivo of 
novel antifungals is essential for discovering new treatments to combat invasive aspergillosis and improve prognosis of patients. As 
such, this study proposed the use of the greater wax moth, Galleria mellonella, as a quick way to model A. calidoustus infection. Due to 
the dangers of working with A. calidoustus in a high school setting, A. ustus was used in experimentation. It was hypothesized that G. 
mellonella would be susceptible to infection by A. ustus and, thus, could be used to model A. calidoustus infection in humans. It was 
also hypothesized that larval mortality would be dose-dependent. Concentrations of 1 x 103, 1 x 104, and 1 x 105 spores of A. ustus per 
10 µL were injected into the G. mellonella larvae, and survival was measured over 96 hours. Larval survival was found to be high, with 
only the larvae infected with 1 x 104 spores being significantly different from the untouched control larvae through a log-rank test, X2(1, 
N=10)=3.89, p=0.0486. This did not support the hypothesis that larval mortality would be dose-dependent, and it implied that G. 
mellonella was not a viable model for A. ustus infections. However, factors such as low sample size, low temperature, and low spore 
concentrations may have affected the data, so G. mellonella should not be abandoned as a model for A. calidoustus infections without 
further research. 
 
Introduction 
 
Invasive aspergillosis has become a cause of serious mortality and morbidity for immunocompromised patients. Incapable of providing a proper 
immune response against fungal infection, patients with HIV/AIDS, leukemia, haematopoietic stem cell transplantation, and the like rely on a 
multitude of potent antifungals. However, some fungal isolates have been found to display reduced susceptibility to these antifungals, and doctors 
find it increasingly difficult to treat these infections. One species of particular interest is Aspergillus calidoustus, a rare infectious agent 
characterized by its intrinsic pan-resistance to all major classes of antifungals.1 Despite often being associated with poor outcome in patients, A. 
calidoustus remains poorly understood, as there is little research on the subject.2 
Aspergillus calidoustus is a fungal species that is commonly found in groundwater samples and soil.3 It is an emerging causal agent of invasive 
aspergillosis and has demonstrated intrinsic reduced susceptibility to amphotericin B, itraconazole, and voriconazole both in vitro and in vivo.4,2 
Additionally, breakthrough infections in severely immunocompromised patients are common as a result of its innate resistance to azole antifungals, 
which are commonly used for prophylactic treatment.5 Its multidrug resistance makes it more difficult to treat than other fungal species, and a 
higher mortality rate has been associated with A. calidoustus in comparison to other Aspergillus species in primary cutaneous aspergillosis (PCA) 
patients.2 
A recent study compared the mechanisms of azole resistance in A. calidoustus to more common Aspergilli.6 Akin to azole-resistant A. fumigatus, A. 
calidoustus was found to have point mutations on the cyp51B protein complex and the cyp51C protein complex, the latter of which was previously 
only associated with Aspergillus flavus. Both complexes contain lanosterol 14-ɑ-demethylase, an important protein in the biosynthetic pathway of 
producing ergosterol, which forms the main component of the fungal cell wall. These mutations prevent the binding of azole antifungals onto the 
protein’s surface, allowing for the continued production of ergosterol for fungal cell membrane integrity. Additionally, A. calidoustus was found to 
have coding regions for the overexpression of two Cdr1B efflux transporter proteins, which actively pump out the azole antifungal from the fungal 
cell. 
Prior to its identification in 2008, clinical manifestations of A. calidoustus were incorrectly attributed to A. ustus.7 Both are species of Aspergillus 
section Usti and display many similarities; however, they are chiefly distinguished by the temperature at which they can grow. A. calidoustus 
proliferates at 37℃, whereas A. ustus is not able to grow at that temperature and, thus, is incapable of infecting humans. However, A. ustus has 
displayed similar resistance patterns to A. calidoustus, such as elevated minimum inhibitory concentration (MIC) values for voriconazole.8 The 
similarities between these two organisms imply that A. ustus can be used as a safer homologue for A. calidoustus infection, albeit at temperatures 
less than 37℃. 
Invertebrate models of fungal infection have been shown to be in concordance with murine models of human fungal infections. Additionally, they 
are considerably less expensive, more ethical, and easier to handle than murine models. One organism commonly used as a model for fungal 
infections is Galleria mellonella, or the greater wax moth. The larvae of G. mellonella present a viable model of the human innate immune system’s 
response to fungal infections as well as a model for the identification of novel antifungal compounds.9 G. mellonella haemocytes are homologous to 
mammalian neutrophils, and a similar response to A. fumigatus toxin fumagillin during infection has been reported between both humans and the 
wax moth.10 As such, Galleria mellonella shows potential for being an effective model for screening new and alternative antifungal compounds in 
vivo against Aspergillus ustus and, through comparison, A. calidoustus. 
The purpose of this experiment was to evaluate the viability of Galleria mellonella as a model of Aspergillus calidoustus infection. Although 
studies have demonstrated G. mellonella larvae to be a practical model for Aspergillus fumigatus and Aspergillus terreus infection, no studies thus 
far have evaluated wax moth larvae as a model for species of Aspergillus section Usti.11-12 Moreover, at the time of the study, no in vivo models of 
infection caused by species of Aspergillus section Usti had been completed in general. Thus, this research aimed to determine the lowest 
concentration of A. ustus conidia that resulted in infection and death of G. mellonella. This would aid in the future use of G. mellonella as a model 
to assess the efficacy of novel antifungals rapidly against A. ustus and A. calidoustus. 
It was hypothesized that Aspergillus ustus would be able to infect the G. mellonella larvae in a dose-dependent manner, meaning that a greater 
inoculum concentration of spores would result in increased mortality of larvae over a 96 hour time period. 
To test this, Galleria mellonella were inoculated with 1 x 105, 1 x 106, and 1 x 107 A. ustus spores per larva. Larvae were then monitored at 24 hour 
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increments over a period of 96 hours at 30℃ in order to determine the capability of A. ustus to infect and kill G. mellonella larvae and thus indicate 
the viability of the wax moth larva as a model for screening novel antifungals against species of Aspergillus section usti in vivo. 
 
Methods 
 
Aspergillus ustus ATCC 10760 (VWR, Radnor, PA) were grown on potato dextrose agar plates for 48 hours at 30℃. Colonies were then 
transferred aseptically to potato dextrose agar slants and grown once more at 30℃. After 28 days, the fungal cultures were flooded with 0.85% 
saline solution, and colonies were gently scraped with a sterile micropipette tip to harvest conidia. The conidia-saline suspensions were then 
transferred to three sterile test tubes until each had a volume of ~ 3 mL. To evenly distribute conidia, suspensions were mixed by drawing up and 
down with a micropipette. A volume of 10 µL from each suspension was transferred to a Bright-Line™ hemocytometer (Sigma, St. Louis, MO), and 
conidia were counted to 1 x 107 conidia mL-1. Two suspensions were then serially diluted 10-fold and 100-fold, respectively, to the concentrations 
of 1 x 106 and 1 x 105 conidia mL-1. 
Larval Inoculation and Mortality: 
Larvae of the greater wax moth, Galleria mellonella (Carolina Biological, Burlington, NC) arrived in a plastic container filled with nutritive 
medium. Upon reaching the sixth instar stage, larvae were randomly separated into their respective experimental or control groups to begin 
experimentation (Figure 1). Larvae were picked up between the thumb and forefinger, and the needle of the hypodermic syringe (1 cc in 1/100 cc, 
23 gauge, 1.0 inch needle) was inserted into the last left proleg. A volume of 10 µL of the A. ustus conidial suspensions were injected into the 
larvae, so that larvae received 1 x 103, 1 x 104, or 1 x 105 conidia. Larvae were then placed five each in a petri dish. Additionally, controls of five 
larvae injected with 10 µL of the 0.85% saline solution and five untouched larvae were placed into petri dishes. 
Each petri dish was incubated for 96 hours at 30℃. Larval mortality was monitored every 24 hours by counting the number of living and dead 
larvae in each petri dish. Larvae were considered dead if they appeared black or brown or did not respond to touch with forceps (Figure 2). Larval 
behaviors such as the formation of cocoons and pupation were recorded as well. 
Safety Precautions: 
All experimentation was completed under a fume hood in order to prevent the spread of A. ustus spores in the laboratory. Moreover, aseptic 
technique was practiced in order to prevent contamination of lab equipment and surfaces. Nitrile gloves and goggles were worn at all times 
throughout experimentation to prevent unwanted exposure to organisms and chemicals. G. mellonella larvae were housed in plastic containers with 
holes at the top and lidded petri dishes in order to prevent their escaping into the laboratory. Additionally, G. mellonella larvae were all disposed of 
by being frozen, being sealed in a plastic bag, and being placed in the trash.13 A. ustus cultures were subjected to a 10% bleach solution, and Lysol 
wipes were used to clean the lab area after experimentation was completed. 
Statistical Analysis: 
Survival rates of G. mellonella larvae were evaluated using Kaplan-Meier survival curves and compared using the log-rank (Mantel-Cox) test at α = 
0.05. All statistical analyses were completed using GraphPad Prism 7. 
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Results  
 
Survival data of G. mellonella was collected for larvae infected with 1 x 103 spores, 1 x 104 spores, and 1 x 105 spores, as well as larvae injected 
with a saline solution and untouched larvae over a 360 hour time frame (Tables 1 -5). The number of living larvae, dead larvae, cocoons/pupa, and 
wax moths in each group were recorded on each day at approximately the same time, excluding weekends. Larvae infected with 1 x 105 spores 
either died or completed metamorphosis by 360 hours, while none of the larvae infected with 1 x 104 spores completed metamorphosis, and four-
fifths perished. All of the larvae infected with 1 x 103 spores spun cocoons, but none of them completed metamorphosis. Both untouched larvae and 
larvae injected with a saline solution had one death and four larvae complete metamorphosis. 
 
Figure 2. Types of dead larvae found during experimentation. Larvae whose deaths were attributed to three different causes are 
shown above. From left to right, this image shows larvae who died from being pierced by a needle, being victim to 
cannibalization, and being infected by A. ustus. Each is an example of a larva that was considered “dead” during 
experimentation.  
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The data were then used to create Kaplan-Meier survival curves to model G. mellonella larvae mortality over 96 hours (Figure 3). Of the three 
inocula concentration groups, larvae infected with 1 x 104 spores had the lowest survival rate, whereas larvae infected with 1 x 103 spores appeared 
to have the greatest survival rate. However, larvae infected with 1 x 103 spores became censored 48 hours after infection. All five of the larvae in 
this group formed cocoons, preventing the further collection of mortality data. 
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Larvae infected with 1 x 105 spores were the first group to succumb to infection, 48 hours after experimentation began. Two of the five larvae died 
at this time point, but afterwards no other larvae in this group perished. At 72 hours post-infection, mortality was first recorded for larvae injected 
with 1 x 104 spores. Unlike larvae infected with 1 x 105 spores, percent survival continued to decrease at 96 hours for this group. The Kaplan-Meier 
curve for the untouched control displayed 100% survival for all the larvae over the 96 hour time frame. In the saline control group, however, 
mortality was observed at 96 hours. 
A log-rank test (Mantel-Cox) was run to compare the Kaplan-Meier curves at alpha = 0.05. Results were found to be non-significant, X2(4, N = 25) 
= 7.42, p = 0.1153. However, each inoculum concentration was also compared individually with the untouched control. Only the Kaplan-Meier 
curve of larvae infected with 1 x 104 spores was found to be significantly different from that of the untouched control, with X2(1, N = 10) = 4.464, p 
= 0.0486.   
The differences between the untouched larvae and larvae infected with the 1 x 105 spores and 1 x 103 spores were both non-significant, with X2(1, 
N = 10) = 2.25, p = 0.1336 and X2 (1, N = 10) = 0, p = 0.9999, respectively. 
Because some of the larvae formed cocoons during experimentation, the number of moths that completed pupation was counted after 15 days. The 
remaining larvae infected with 105 spores successfully formed cocoons and developed into viable wax moths. However, neither of the remaining 
larvae inoculated with 1 x 104 spores completed the pupal stage, nor did any of the five larvae inoculated with 1 x 103 spores. Interestingly, one of 
the untouched larvae came out of its cocoon and died for no apparent cause, but the remaining four larvae all became moths. The remaining larvae 
of the saline control all finished pupation and transformed into moths as well. 
 
Discussion 
 
Antifungal resistance is currently a major concern for both caregivers and patients. In particular, infections by multidrug-resistant species, such as 
A. calidoustus, are difficult to treat because of their resistance to current treatments. Moreover, it is necessary that doctors be able to rapidly screen 
novel antifungals against such species in vivo. A promising model for antifungal testing in vivo is the greater wax moth, Galleria mellonella. As 
such, the goal of this research was to determine whether Galleria mellonella could be a viable model for Aspergillus calidoustus infections through 
the use of the genetically and morphologically similar A. ustus. It was hypothesized that A. ustus would be capable of infecting G. mellonella, with 
an increasing spore dosage correlating to an increase in wax moth mortality over 96 hours. Mortality data of wax moths infected with increasing 
doses of A. ustus spores (1 x 103,1 x 104, and 1 x 105) was collected over a 96 hour period. 
A log-rank test (Mantel-Cox) found that there were no significant differences between the Kaplan-Meier survival curves for each group when they 
were all compared at alpha = 0.05, X2 (4, N = 25) = 7.42, p = 0.1153 (Figure 3). Considered individually, however, a significant difference was 
found between survival curves of larvae infected with 1 x 104 spores and larvae of the untouched control, X2 (1, N = 10) = 3.89, p = 0.0486. The 
other experimental groups and the saline control were not found to be significantly different from the untouched control (p > 0.05). Therefore, the 
hypothesis that larval mortality would be dose-dependent was not supported by the log-rank test or the Kaplan-Meier curves, as the data showed 
that the greatest mortality occurred in larvae infected with 1 x 104 spores rather than those infected with 1 x 105 spores. Even at this concentration, 
larval mortality was only slightly greater than 50% after 96 hours. 
Thus it appears that G. mellonella is not an appropriate model of A. ustus infections. The data support that G. mellonella is little affected by its 
inoculation with A. ustus spores. It should be noted, however, that the spore concentrations tested in this study were significantly lower than those 
used in prior studies. Maurer et al. (2015) assessed whether spore dosage and temperature affected G. mellonella prognosis after infection with A. 
terreus. Testing with spore concentrations of 1 x 105 - 1 x 107 per larva, the authors found that larval survival was inversely related to spore 
concentration and incubation temperature. At the optimal growth temperature for A. terreus, 37℃, a dose of 1 x 105 spores resulted in 50% larval 
mortality. Similarly, infection by A. ustus with a dose of 1 x 104 spores produced >50% mortality in larvae in this research at its optimal growth 
temperature of 30℃. Infection with 1 x 106 or 1 x 107 spores of A. ustus per larva, therefore, may decrease survival of G. mellonella and increase its 
viability as a model for Aspergillus ustus infections.
Figure 3. Kaplan-Meier survival estimator of mortality of G. mellonella larvae over 96 hours. Kaplan-Meier survival curves show G. 
mellonella larval mortality at different concentrations of spore inocula. Five larvae in  each group were either infected with a spore 
solution, injected with a saline control, or left untouched. No larva in the untouched control died during the 96 hour period, while a single 
larva died in the saline control. Larvae injected with 1 x 103 spores were censored at 48 hours. Only the group of larvae injected with 1 x 
104 spores had less than a 50% survival rate, but they began to die later (72 hours) than larvae injected with 1 x 105 spores (48 hours).  
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As Maurer et al. concluded, incubation temperature also plays a role in the capacity of G. mellonella larvae to succumb to infection.12 In the case of 
A. terreus, a higher temperature (37℃ versus 30℃) was associated with increased larval mortality. However, A. ustus is unique among Aspergilli in 
that is incapable of growing at temperatures greater than 30℃. As such, 30℃ would have been the optimal temperature for A. ustus pathogenesis. 
However, Kwadha, Ong’amo, Ndegwa, Raina, and Fombong reported that the temperature range of 29-33℃ is optimal for the development of G. 
mellonella larvae and that temperatures above this range can impair development.14 To determine whether temperature contributes to larvae 
immune response to fungal infection, García-Rodas, Casadevall, Rodríguez-Tudela, Cuenca-Estrella, and Zaragoza tested for the level of 
phagocytosis of larval haemocytes on Cryptococcus neoformans at 30℃ and 37℃, finding that the larval immune system was impaired at the latter 
temperature.15 
Therefore, larvae infected with A. ustus spores at 30℃ may have had a primed immune system. The increased phagocytic activity of larval 
haemocytes could have lowered the ability of A. ustus spores to kill G. mellonella larvae and thereby reduced the apparent viability of the G. 
mellonella model for such fungal infections. Future research could focus on using the more virulent A. calidoustus, which is capable of growth at 
37℃, at which the larval immune system is impaired. Additionally, a greater number of larvae could be used to evaluate the efficacy of the G. 
mellonella model, as this study only tested with groups of 5 larvae. Larger groups, with sample sizes of 10 or 20 larvae, would make the results 
more comprehensive and conclusive. Furthermore, a macroscopic dissection of larvae and histological analysis would be completed in the future to 
better understand A. ustus and A. calidoustus pathogenesis. 
It should also be acknowledged that larvae were in various instar stages during experimentation. Although the majority of chosen larvae were in the 
5th fifth instar stage, a few larvae may have been in earlier or later stages. For instance, one larva infected with 1 x 104 spores committed an act of 
cannibalism, eating another larva. Such behavior generally occurs when larvae are in starved conditions; however, fifth instar larvae stop eating, so 
this behavior implies that some larvae were in an earlier stage. Moreover, many larvae formed cocoons during experimentation. Although this was 
handled by counting the number of wax moths that completed metamorphosis, the formation of cocoons may have skewed the data by making it 
impossible to determine whether larvae were living or dead, especially since there were so few larvae in the study. As such, future research should 
use larvae that are stored at reduced temperatures of around 15℃ to halt larval development past the instar stages and to prevent the formation of 
cocoons. 
In conclusion, this study was the first to evaluate G. mellonella as a potential model for infections caused by A. ustus, a species of Aspergillus 
section Usti. The data support that G. mellonella is not an appropriate model for invasive aspergillosis caused by Aspergillus ustus. However, low 
sample size, low spore concentrations, and low temperature may have decreased the viability of the larvae as such a model. Experimentation with 
A. calidoustus and immunocompromised G. mellonella larvae at 37℃  has yet to be completed, so G. mellonella should not be abandoned as an 
easy-to-use and inexpensive model for A. calidoustus infections. 
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